Edition:
India

Citius Pharmaceuticals Inc (CTXR.OQ)

CTXR.OQ on NASDAQ Stock Exchange Capital Market

2.88USD
20 Apr 2018
Change (% chg)

$0.11 (+3.97%)
Prev Close
$2.77
Open
$2.83
Day's High
$2.88
Day's Low
$2.76
Volume
11,968
Avg. Vol
8,282
52-wk High
$5.46
52-wk Low
$0.34

Latest Key Developments (Source: Significant Developments)

Citius Pharmaceuticals To Sell Up To 1.4 Mln Shares Of Co's Common Stock
2:33am IST 

April 20 (Reuters) - Citius Pharmaceuticals Inc ::CITIUS PHARMACEUTICALS - TO SELL OR OTHER DISPOSITION FROM TIME TO TIME OF UP TO 1.4 MILLION SHARES OF CO'S COMMON STOCK.  Full Article

Citius Announces $6 Mln Registered Direct Offering Priced At-The-Market
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Citius Pharmaceuticals Inc ::CITIUS ANNOUNCES $6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET.CITIUS PHARMACEUTICALS - ENTERED AGREEMENTS WITH SEVERAL INSTITUTIONAL, ACCREDITED INVESTORS TO BUY 1.3 MILLION SHARES AT $4.6925/SHARE.  Full Article

Citius Pharmaceuticals Says On Nov 27, Board Appointed Jaime Bartushak As CFO And Principal Financial Officer Of Co
Saturday, 2 Dec 2017 

Dec 1 (Reuters) - Citius Pharmaceuticals Inc ::CITIUS PHARMACEUTICALS INC - ‍ON NOV 27, , BOARD APPOINTED JAIME BARTUSHAK AS CFO AND PRINCIPAL FINANCIAL OFFICER OF COMPANY, EFFECTIVE NOV. 27, 2017​.  Full Article

Citius Pharmaceuticals files for mixed shelf offering of up to $50 mln - SEC filing‍​
Friday, 10 Nov 2017 

Nov 9 (Reuters) - Citius Pharmaceuticals Inc :Citius Pharmaceuticals Inc - files for mixed shelf offering of up to $50 million - SEC filing‍​.  Full Article

Citius pharmaceuticals receives "fast track" designation by FDA for mino-lok™ investigational trial
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Citius Pharmaceuticals Inc :Citius Pharmaceuticals, Inc. Receives "fast track" designation by FDA for mino-lok™ investigational trial.  Full Article

BRIEF-Citius Pharmaceuticals To Sell Up To 1.4 Mln Shares Of Co's Common Stock

* CITIUS PHARMACEUTICALS - TO SELL OR OTHER DISPOSITION FROM TIME TO TIME OF UP TO 1.4 MILLION SHARES OF CO'S COMMON STOCK Source : https://bit.ly/2JdehV7 Further company coverage: (Reuters.Briefs@thomsonreuters.com)